Andre Herbelin
Overview
Explore the profile of Andre Herbelin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Decroos A, Meddour S, Demoy M, Piccirilli N, Rousselot P, Nicolini F, et al.
Front Immunol
. 2024 Dec;
15:1473139.
PMID: 39620210
Considering the general view that unconventional immune effectors play a major role in antitumor immunity, we recently postulated that the distinct new innate CD8 T-cell pool (co-expressing the transcription factor...
2.
Robin A, Mackowiak C, Bost R, Dujardin F, Barbarin A, Thierry A, et al.
Front Immunol
. 2023 May;
14:1099529.
PMID: 37228593
Over the past thirty years, the complexity of the αβ-T cell compartment has been enriched by the identification of innate-like T cells (ITCs), which are composed mainly of invariant natural...
3.
Viano M, Baez N, Savid-Frontera C, Lidon N, Hodge D, Herbelin A, et al.
J Interferon Cytokine Res
. 2022 Sep;
42(12):624-642.
PMID: 36083273
The presence of CD8 T cells with a memory phenotype in nonimmunized mice has been noted for decades, but it was not until about 2 decades ago that they began...
4.
Barbier L, Robin A, Sindayigaya R, Ducousso H, Dujardin F, Thierry A, et al.
Front Immunol
. 2021 Oct;
12:744927.
PMID: 34621275
Ischemia and reperfusion injury is an early inflammatory process during liver transplantation that impacts on graft function and clinical outcomes. Interleukin (IL)-33 is a danger-associated molecular pattern involved in kidney...
5.
Daniel L, Tassery M, Lateur C, Thierry A, Herbelin A, Gombert J, et al.
Front Immunol
. 2021 Aug;
12:674016.
PMID: 34367138
Immunosenescence is a physiological process that is associated with changes in the immune system, particularly among CD8 T-cells. Recent studies have hypothesized that senescent CD8 T-cells are produced with chronologic...
6.
Dufour L, Ferhat M, Robin A, Inal S, Favreau F, Goujon J, et al.
Nephrol Ther
. 2020 Jun;
16(6):388-399.
PMID: 32571740
Ischemia-reperfusion injury is an inescapable phenomenon in kidney transplantation. It combines lesional processes of biochemical origin associated with oxydative stress and of immunological origin in connection with the recruitment and...
7.
Cayssials E, Torregrosa-Diaz J, Gallego-Hernanz P, Tartarin F, Systchenko T, Maillard N, et al.
Cancer
. 2020 May;
126(15):3438-3447.
PMID: 32459375
Background: Long-term treatment-free remission (TFR) represents a new goal for chronic myeloid leukemia (CML). In clinical practice, tyrosine kinase inhibitor (TKI) dose reductions can be considered a means of preventing...
8.
Barbarin A, Abdallah M, Lefevre L, Piccirilli N, Cayssials E, Roy L, et al.
Sci Rep
. 2020 Feb;
10(1):3245.
PMID: 32094501
Kinase inhibitors hold great potential as targeted therapy against malignant cells. Among them, the tyrosine kinase inhibitor dasatinib is known for a number of clinically relevant off-target actions, attributed in...
9.
Barbier L, Ferhat M, Salame E, Robin A, Herbelin A, Gombert J, et al.
Front Immunol
. 2019 Sep;
10:2014.
PMID: 31507607
The pyrogenic property being the first activity described, members of the interleukin-1 superfamily (IL-1α, IL-1β, IL-18, and the newest members: IL-33, IL-36, IL-37, and IL-38) are now known to be...
10.
Cayssials E, Jacomet F, Piccirilli N, Lefevre L, Roy L, Guilhot F, et al.
Br J Haematol
. 2019 Mar;
186(1):54-59.
PMID: 30864168
Immunological mechanisms of treatment-free remission (TFR) in chronic myeloid leukaemia (CML) are poorly defined and, to date, no correlation between successful TFR and CD8(+) T-cell subsets has been found. We...